Results of a secondary analysis of data from the ASPREE trial quantified the CVD burden for older adults after cancer and its treatment.

Researchers sought to determine whether high antimetabolite dose intensity is related to higher treatment-induced toxicity in pediatric patients with ALL.

Researchers conducted a cross-sectional study to assess the prevalence of gender-affirming surgeries among transgender and gender-diverse children in the US.

For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab yields a significant improvement in overall survival ...

Patients who received subcutaneous daratumumab plus bortezomib, lenalidomide, and dexamethasone (VRd) had better outcomes than patients who received VRd alone.